Alpha-l-proteinase inhibitor activity was studied in presence of resting and activated polymorphonuclear leucocytes. Four different agonists; phorbol myristic acetate, N-formyl-methionylleucyl-phenylalanine, opsonised zymosan and arachidonic acid decreased the inhibitor activity by 23.3%, 20%, 12% and 16.6% respectively. The inhibitor activity was protected by using various free radical scavengers. Catalase and superoxide dismutase both restored activity by about 18 %, mannitol by 13% and sodium azide by 17.3%. The inhibitor activity was also protected significantly by pretreatment of polymorphs with L-Arg, a precursor of nitric oxide, before activation. L-Arg was also observed to suppress the generation of superoxide and hydroxyl radical appreciably. The nitric oxide synthase inhibitor, aminoguanidine drastically inhibited the nitrite release and reversed the protection offered by L-Arg to the inhibitor activity. Our results indicate a multifactorial nature of the inactivation process, the culprit species being superoxide, hydrogen peroxide, hydroxyl radical and hypohalides. Nitric oxide seems to scavenge the superoxide radical directly after its formation rather than inhibiting its generation by NADPH oxidase as was believed earlier.
INTRODUCTION
Polymorphonuclear leucocytes (PMNLs), as a part of their cytocidal activity, release reactive oxygen species (ROS) in their surrounding medium (1, 2, 3, 4) . The ROS include superexide (Oz), nitric oxide (NO), hydrogen peroxide (H2Oz), hydroxyl radical (-OH) and hypohalides. Nitric oxide and superoxide combine to form peroxynitrite, a relatively long lasting oxidant and hydroxyl radical, a much lethal species (5, 6, 7) . ROS modulate Ca 2. signaling and protein phosphorylation events and thereby function as regulators of various biological processes including gene expression, cell growth, differentiation, chemotaxis, apoptosis and defense mechanisms (6, 9, 10 ).
The role of NO is diverse varying from an endogenous modulator of airway function to a pro-inflammatory and immunomodulatory mediator in patho-physiological conditions (5, 11, 12) . Clancy et al. (13) reported the
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inactivation of API by the activated PMNLs using four agonists, phorbal mydstic acetate (PMA), N-formylmethionyl-leucyl-phenylalanine(FMLP), opsonized zymosan(OZ) and arachidonic acid (AA).The role of NO in the inactivation process was also studied by including the L-Arg ( a precursor of NO) in the activated PMNL suspensions.
MATERIALS AND METHODS
Human serum albumin, cytochrome-C (type III), porcine pancreatic elastase (EC 3.4.21.36) horseradish peroxidase (EC 3.4.21.4), superoxide dismutase (EC 1.15.1.1) fumed silica, dithiothreitol (D'I-I'), dimethyl sulphoxide, triton-X-100, N-succinyI-L-ala-L-ala-L-alapara-nitroanilide (SLAPN), dextran-500, LArg, trypan blue, aminoguanidine, 4-aminophenazone, phorbol-12-mydstate, N-formyl-methionyl-leucyl-phenylalanine , arachidonic acid, zymosan, DEAE-cellulose, naphthyl ethylene diamine dihydrochloride (NEDD), acrylamide, NIN ~-methylene bisacrylamide 0 ammonium / / persulphate , sodium dodecyl sulphate, N N-N N tetramethyl ethylenediamine, Krebs dnger phosphate buffer (KRPB), Hanks balanced salt solution (HBSS) and brilliant blue R were purchased from Sigma (St. Louis, MO, USA). The other chemicals of analytical grade were obtained from standard Indian sources.
Isolation and purification of API API was purified from human plasma according to the procedure recommended by Glaser et aL (26) with some modifications. 200 ml of freshly separated human plasma was obtained from blood bank of Sher-I-Kashmir Institute of Medical Sciences (SKIMS) and was diluted with equal volumes of 0.1M tris buffer pH 8.5, DTT and fumed silica were added to final concentration of 25mM and 2.5% respectively and the contents were stirred at 25~ for 24 hours on a magnetic stirrer. The DTT treated plasma was salted out in 50 % ammonium sulphate at 4~ and was equilibrated overnight. The precipitated plasma proteins were centrifuged at 500g for one hour in a refrigerated centdfuge. The supematant was removed and dialyzed against 10 mM sodium phosphate buffer pH 7.6. The dialysate was loaded on a DEAE-cellulose column (15x2.5 cm) equilibrated with 10 mM sodium phosphate buffer pH 7.6 to a concentration of 40 mg protein ! ml resin. The column was washed with equilibrating buffer until the O.D. of the eluted buffer at 280 nm approached zero. API was eluted with a gradient of 0.01M sodium phosphate and 0.2M NaCI. 3.0 ml fractions were collected and fractions having a specific activity greater than 0.5 were pooled. The pooled fractions were concentrated and subjected to gel chromatography on Sephadex G-25. The fractions containing API were again pooled and lyophilized. The specific extinction co-efficient of 0.5 (at 280 nm) was used to determine protein concentration of purified
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product. The purity of isolated proteins was judged by SDS-PAGE.
Elastase inhibitory activity (EIA) of API EIA was determined according to the method of Beatty et al. (27) using the synthetic substrate, SLAPN. The API inhibits the hydrolysis of SLAPN by elastase and the degree of this inhibition by API gives elastase inhibitory activity. 5.0 ml of stock elastase solution (5 mg/ml in 0.05M tris -NaCI, pH 8.0) was mixed with 100 Id of 0.2 M tris-HCI, pH 8.0 in a 1.0 ml cuvette. The volume was adjusted to 1.0 ml by addition of 0.05 M tris-HCL pH 8.0 and 20 ml of stock SLAPN (30 mg/ml in DMSO) was added. Elastasa activity was measured as the change in the absorbance per minute at 405 rim.
Elastase activity (l~mol/min/ml) = Assay volume (ml) x /k A,~/10.5 x sample volume (ml) x'13me (min)
Where 10.5 is the molar extinction coefficient of paranitroanilide at 405nm liberated on hydrolysis of substrate. For EIA, 20 pl of sample (API) was mixed with 100 I~1 of 0.2 M tris HCL buffer pH 8.0 in 1 ml cuvette and was treated exactly as described above for the elastase activity. The residual elastasa activity was determined and was used to calculate EIA as under:. EIA = Elastase activity -residual elastasa activity.
Isolation of PMNLs
The PMNLs were isolated according to the method described earlier (25) . Ten ml random blood sample was collected in a heparinized syringe (from apparently healthy and nonsmoker volunteers, mostly SKIMS employees) and mixed with 6% (w/v) Dextran-500 in normal saline in ratio of 4:1 and allowed to stand for 60 min. at room temperature. The supematant was aspirated into a plastic tube and centrifuged at 275g for 10 min. The resulting pellet was resuspended in 8.0 ml of KRPB and layered over 3.0 ml cold histopaque-1077 and centrifuged for 20 min at 100 g. The supematant was aspirated up to approximately 0.5 cm above the PMNL layer and the sides of the tube were cleaned with a sterile and clean cotton swab to remove any contaminating adherent cells. The RBCs present in the cell pellet ware lysed by adding 9 volumes of distilled water to this, followed by vigorous shaking for 30 sec. using a cyciomixer. Osmoladty was restored by adding 1o0 ml 9% NaCI. The cell suspension was again centrifuged at 275 g for 5min and the resultant pellet was washed three times with KRPB and finally suspended in 1-2 ml of KRPB. Cells were counted and viability was established by trypan blue test. The experiments involving PMNL were organized in such a way that .the whole exercise was completed in one working day without the overnight disruption.
PMNL activating agents
Four different agonists were used for the activation of PMNL. Stock solutions were prepared and divided in small aliquots and stored at requisite temperatures as descdbed below.
1. PMA:StocksoluUons(1 mg/ml) was made in DMSO and stored at-20~ 2. AA: Stock solution (2.6 mM) was made in DMSO and stored at-20~ .
4.
FMLP: Stock solution of FMLP (10 raM) in DMSO was prepared and stored at -20~
Opsonised zymosan (OZ): 15 mg of zymosan was boiled in 1.0 ml of distilled water till a paste was formed. After cooling 1.0 ml human serum was added and the contents were incubated at 37~ for 30 rain. Zymosan was centrifuged at 300g for 10 minutes at room temperature and resuspended in phosphate buffer saline for a final concentration of 15 mg/ml. The suspension was divided into 0.2 ml aliquots and stored at-70~
Estimation of superoxide
The amount of superoxide generated was estimated by measuring the SOD-inhibitable reduction of cytochrome C as described eadier (25) . 2x106 cells/ml suspended in KRPB were pipetted into three clean plastic tubes each containing cytochrome C solution (100 ~M in KRPB). SOD was added to one of the tubes to a final concentration of 100 ug/ml. Alter incubation for 5 min at 37~ , the stimulants at appropriate concentrations were added to the other tube. All the tubes were shaken and incubated at 37~ for 10 rain in water bath. After incubations , the tubes were immediately transferred to a beaker containing melting ice and were centdfuged to remove the cell debris at 400g for 5 min in a refrigerated centrifuge. Cytochrome C reduction was measured by recording the absorbance at 550 nm against a reference solution containing SOD. The absorbance was multiplied by a factor of 47.7 to give superoxide concentration in n moles/2x108 cells/ml/10min.
Determination of hydroxyl radical
The hydroxyl radical generation was measured according to the method described by Greenwald et al. (28) . The method is based on the degradation of deoxydbose by the hydroxyl radical to a chromogen which is read at 532 nm. To freshly isolated PMNL (2xl06cells) suspended in 0.2 ml HBSS buffer was added 0 9 ml of deoxydbose solution (20 raM) and 0.1 ml ferdc-EDTA reagent. The reaction was started by adding optimized concentration of activator. The volume was made to 1 9 ml by HBSS. A blank, in which activator was omitted was also run. The reaction mixture was incubated at 37~ for 60 min. The contents were centrifuged at 500 g for 5 mino 0.5 ml TCA was added to 0.8 ml of supematant, the contents were vortexed and 0.5 ml thiobarbituric acid reagent was added. After mixing well, the mixture was heated in a boiling water bath for 30 min. The absorbance of the resulting pink colour was recorded at 532 nm. The hydroxyl radical generation was quantified in terms of MDA equivalents using a standard curve for MDA estimation.
Determination of nitrite
Nitrite was measured by Greiss reaction (29) . The working Greiss reagent was freshly prepared by mixing equal volumes of NEDD and sulphanilamide (3.8 and 58 mM respectively made in 5 % phosphoric acid). 2x106 PMNL suspended in HBSS, pH 7.4 were pre-
treated with 15 mM L-Arg for 10 minutes before stimulants were added to each reaction mixture. The final volume was made up to1.0 ml with HBSS. The reaction mixture was incubated at 37~ for 60 rain. in a shaking water bath and the contents were centdfuged at 500g for 5 min. at 4~ 0.5 ml of supematant was mixed with 0.5 ml of Greiss reagent and incubated for 15 minutes at 25~ The absorbance was read at 550 nm against reagent blank 9 A standard curve was plotted with NaNO 2 in the concentration range of 0-2 raM, which was used to calculate the nitrite concentration in unknown samples.
RESULTS
API was isolated from 200 ml of human serum containing 12.52 g of total protein with 650 units of API activity. The first purification step, involving 50% ammonium sulphate precipitation in presence of D'l-r and fumed silica resulted in 9.8 fold purification. The specific activity increased almost 10 fold from 0.052 to 0.512, although recovery of total activity was only 52.3%. After the second step in which DEAE-Cellulose column chromatography was carded out (Fig.l) , the specific activity increased to 0.7 with an overall purification of 13.4 fold. Thirty four fractions were pooled which had total API activity corresponding to 33.8 % of original. The pooled fractions gave a single band on SDS-PAGE indicating its homogeneity (Inset of Fig. 1 ). The optimal activator concentration, PMNL population and incubation time were worked out in preliminary experiments. It was found that optimal concentration of PMA, FMLP, OZ and AA for PMNL stimulation were 0.01 I~g/ml, 4.3 p.g/ml, 1.5 mg/ml and 15.2 p.g/ml respectively. A uniform population of PMNL (2 x 106 cells/ml) was used for all the activators and the optimum incubation time was found to be 30 min at 37oC.
The API activity remained unaltered on pre-incubation of API with resting PMNL. However when PMNL were activated with PMA, API activity was reduced to 76.7%. The decrease in API activity was 20%, 12% and 16.6% (2) , OZ (3) and AA (4) .
when PMNL were activated with I FMLP, OZ and AA respectively (Fig. 2) . The inclusion of scavengers of reactive oxygen species resulted in the improvement of EIA. SOD and catalase restored about 18.0% of EIA, whereas mannitol, a scavenger of hydroxyl radical and sodium azide, an inhibitor of myeloperoxidase restored 13.0% and 17.30% EIA respectively (Fig. 3) . The pretreatment of PMNL with L-Arg before activation by the four agonists protected API against inactivation. The protection offered by L-Arg varied with the type of activator used and was maximum with PMA (Fig 4) . API activity was restored from 65% to 80.10% on activation of L-Arg pre-treated PMNL with PMA. The EIA was restored from 69.40% to 78.20%, from 66.40% to 79.30 % and from 66.20 % to 78.00% when the Arg pre-treated PMNL were activated with FMLP, zymosan and AA respectively (Fig. 4) .
The superoxide generation was studied in freshly pooled PMNL preparations. The total superoxide production was 38.98, 15.44, 20.51 and 28.1 n moles/ 2 x 108 cells/10 min. for PMA, FMLP, OZ and AA respectively. L-Arg. reduced the superoxide production by 14.6%, 32.30%, 26.24% and 68.9% in presence of PMA, FMLP, OZ and AA respectively (Fig. 5) . The total inhibition of superoxide production showed concentration dependence with L-Arg and the maximum inhibition was observed at 14 mM L Arg under our experimental conditions (Fig. 6) . PMA was the most potent inducer of hydroxyl radical generation by PMNL whereas FMLP had no response at all. Hydroxyl radical generation was found to be 114.96, 38.9 and 111.7 ng MDA equivalents of hydroxyl radical for PMA, OZ and AA respectively. As in case of superoxide, L-Arg reduced the generation of hydroxyl radicals. The extent of decrease was 33.98%, 22.16% and 40.46% for PMA, OZ and AA respectively (Fig. 7) The generation of NO in presence of L-Arg was measured in terms of nitrite, since NO is unstable to measure. The L-Arg pretreated PMNLs released significant amounts of nitdte on stimulation with the agonists. The nitdte production was more pronounced by AA both in presence and absence of L-Arg (Fig. 8 ) as compared to other three activators. The effect of nitdc oxide synthase inhibitor, aminoguanidine on API inactivation was also studied. Aminoguanidine decreased the nitdte production by 81% from 1.12 to 0.21 mM in presence of PMA as a stimulant. The protection offered to API against inactivation by L Arg was reversed in presence of aminoguanidine and the API lost 21% EIA (Fig. 9) .
DISCUSSION
In resting PMNLs, the NADPH oxidase is dormant with unassembled subunits located in the cytosol and plasma membrane which gets activated on selective stimuli (1, 30, 31, 32) . All the four agonists used by us inactivated API molecule, though the maximum inactivation was achieved with PMA followed by FMLP, AA and OZ in that order. It is well recognized that more than one signaling pathway can activate the same response in neutrophils (33) . PMA ( a non physiological stimulus) activates cells by stimulating extracellular signal regulated kinases (ERKs) through a PKC dependent pathway, whereas OZ involves the tyrosine kinase, Pyk2 dependent activation of cytosolic phospholipase A2 and the stimulation is further mediated by FC~" receptor and not by complement receptor C3b protein (2, 3, 34) . The precise mechanism for AA mediated activation of NADPH oxidase is still elusive, however several studies suggest that AA induces structural changes in NADPH oxidase components that may promote productive interactions between different oxidase subunits to provide a fully active oxidase or directly affecting the function of flavorcytochrome b (35, 36, 37) . FMLP, a chemoattractant bacterial peptide, is a potent activator of neutrophil degranulation (38) and the activation occurs via diverse pathways including phosphorylation/inactivation of the FO• subfamily of fork-head transcription factors (FKHR, FKHR-L1 and AFX) through the phosphatidylinositol-3-kinase/Akt (protein kinase B) and the RAS mitogen-activated protein kinase pathways (39, 40, 41, 42) .
SOD, a selective scavenger of superoxide and catalase, which decomposes HzO 2, protected the API against oxidative inactivation to some extent. Mannitol, a scavenger of hydroxyl radical and sodium azide also offered protection to API molecule to appreciable and varying extents. These observations demonstrate the multifactodal nature of inactivation process. It seems that 02-, H202, OH and MPO dependent ROS are responsible forAPI inactivation. The role of 02 is pivotal, since it is the precursor of almost all other pro-oxidant species. Hydroxyl radical is believed to be the most lethal species and is formed either spontaneously from H20 = or by metal catalyzed oxidation of H20 z (43, 44) . The lactoferrin released by secondary granules may provide the catalytic iron (as a result of damage by different ROS) which may be responsible for metal dependent generation of hydroxyl radical (45). The pH inside the phagocyte vacuoles of PMNL has been reported to be acidic which is quite conducive for iron release from the lactoferdn. Hydroxyl radical might also be directly generated by the decomposition of peroxynitdte (16).
All the four activators caused a significant increase in nitrite content in PMNL pre-incubated with L-Arg. Arachidonic acid gave the maximum stimulus to PMNL for nitrite generation. Without the L-Arg pretreatment, nitrite generation could not be observed after the activation of PMNL. The pre-treatment of PMNL with LArg caused appreciable decrease in the superoxide and hydroxyl radical generation, the former being LArg concentration dependent. In addition to the mediating endothelial relaxation of vascular smooth muscle (46), inhibiting platelet aggregation and adhesion and mediating tissue damage (47, 48) nitric oxide has also been found to modulate superoxide radical generation (11, 16, 17, 18, 49) . In our studies inclusion of L-Arg. offered protection against PMNL mediated oxidative inactivation, irrespective of the type of activator used. The NOS inhibitor, aminoguanidine suppressed the nitrite release and there was no protection to API inactivation thereby indicating that NO scavenges superoxide so that the later is not available to inactivate API per se or indirectly through the generation of other ROS. The other inhibitors of NOS like L-NMMA and L-NAME were not used because of their non-specificity (50) Our results strongly suggest that O z is scavenged by NO in such a way that oxidative damage to the target protein (API) is minimized. This is contrary to what should be expected alter the generation of peroxynitrite from O z" and NO (11, 15). Possibly NO is metabolized very fast because of its short half life of 1-5 sec. (11) and converted to less lethal species like nitrite and nitrate. Eadier, it was believed that nitric oxide inhibits 02-production at NADPH-oxidase level (13). Contrary to this, our results strongly suggest that nitric oxide scavenges the 02 directly rather than inhibiting the NADPH oxidase. The observation that nitrite release substantially decreased on inclusion of the SOD (which scavenges the superoxide ion ) along with LArg gives enough credence to the belief that nitdc oxide under our experimental conditions, directly scavenges the superoxide radical, resulting in the formation of less toxic species like nitrite which protect 10. the API from oxidative inactivation.
In conclusion, this study on one hand points to the multifactodal nature of oxidative inactivation of API by activated PMNLs in vitro which is reversed by nitric oxide and on the other hand suggests that NO scavenges superoxide directly rather than inhibiting 11. NADPH oxidase.
ACKNOWLEDGEMENT

12.
The authors gratefully acknowledge the facilities provided by Director, SKIMS, Srinagar, proofreading of 13. the manuscript by Dr Nusrat Hussain and the technical assistance by Mr. Mushtaq A Malik and B A Pathan.
